新型药物
Search documents
两部门发布《鼓励外商投资产业目录(2025年版)》 鼓励引导外商投资先进制造业
智通财经网· 2025-12-24 07:35
智通财经APP获悉,近日,经国务院同意,国家发展改革委、商务部全文发布《鼓励外商投资产业目录 (2025年版)》(以下简称《鼓励目录》),自2026年2月1日起施行。新版《鼓励目录》总条目共1679条, 与2022年版相比净增加205条、修改303条。其中,全国鼓励外商投资产业目录(以下简称全国目录)共 619条,增加100条、修改131条;中西部等地区外商投资优势产业目录(以下简称地区目录)共1060条,增 加105条、修改172条。 主要变化有:一是鼓励引导外商投资先进制造业。全国目录新增或扩展终端产品、零部件、原材料等领 域有关条目,提升产业链供应链发展水平。二是鼓励引导外商投资现代服务业。全国目录新增或扩展商 务服务、技术服务、科学研究、服务消费等领域有关条目,促进服务业高质量发展。三是鼓励引导外商 投资中西部地区、东北地区和海南省。结合各地资源禀赋、特色优势和产业发展实际,扩大地区目录鼓 励范围。 原文如下: 鼓励外商投资产业目录(2025年版) (2025年12月15日国家发展改革委令第37号公布 自2026年2月1日起施行) 《鼓励外商投资产业目录(2025年版)》已经国家发展和改革委员会第22 ...
“封闭的水”能促进分子间“联姻”
Ke Ji Ri Bao· 2025-11-12 00:22
Core Insights - The research conducted by German scientists reveals that "trapped water" in specific structures can influence the surrounding environment and facilitate molecular interactions, potentially paving the way for new drug and material development [1][2]. Group 1: Research Findings - The study identifies the phenomenon of "high-energy water," which exists in confined spaces and exhibits energy states higher than ordinary water, impacting molecular binding processes [1][2]. - The research utilized cucurbituril as a "host" molecule, demonstrating that high-energy water molecules are crucial driving forces in molecular binding, with higher energy levels favoring the binding of guest molecules [2]. Group 2: Implications for Medicine and Materials Science - In drug design, recognizing high-energy water in target proteins can aid in the systematic design of active molecules that can replace this water, enhancing drug efficacy by anchoring more firmly to proteins [2]. - In materials science, designing cavities that can expel or replace high-energy water may improve the sensing and storage capabilities of materials [2].
瑞普生物:公司坚持创新驱动高质量发展,积极加快第三代疫苗与新型药物开发
Zheng Quan Ri Bao Zhi Sheng· 2025-09-12 11:08
Core Viewpoint - The company emphasizes innovation-driven high-quality development in response to profound changes in the animal health industry [1] Group 1: Strategic Initiatives - The company is accelerating the development of third-generation vaccines and new drugs [1] - There is a continuous deepening of strategic cooperation with breeding groups [1] Group 2: Long-term Strategies - The company is advancing internationalization, pet economy, and synthetic biology as part of its medium to long-term strategies [1] - These initiatives are aimed at laying a solid foundation for high-quality development and creating long-term investment value for shareholders [1]